Envisagenics, Inc. reported raising in an initial SEC Form D filing, from an offering of $2 Million
Round Type
Venture
Quick answer
Envisagenics raised an undisclosed amount in a funding round, dated March 3, 2017. Envisagenics is based in New York, New York, United States.
- How much did Envisagenics raise?
- Envisagenics raised an undisclosed amount in a funding round on March 3, 2017.
- What does Envisagenics do?
- Envisagenics is an AI-driven biotechnology company harnessing the therapeutic potential of RNA splicing.
- Where is Envisagenics based and how big is it?
- Envisagenics is based in New York, New York, United States.
Source: Fundz verified event record.
Who else raised in Data And Analytics and Science And Engineering around the same time
Companies in the same sectors as Envisagenics that raised within 45 days of this round, from Fundz verified event records.
- Cardurion Pharmaceuticals raised $16M on April 4, 2017.
- Viracta Therapeutics raised $9.9M on April 5, 2017.
- AliveCor, Inc. raised $30M on March 30, 2017.
- QView Medical raised $2M (Seed) on March 13, 2017.
- Gestalt Diagnostics raised $2.6M on March 10, 2017.
- MIXMODE raised $654K (Seed) on February 23, 2017.
Who to call at Envisagenics, and when
A new round usually means Envisagenics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Envisagenics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Envisagenics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Envisagenics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Envisagenics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Envisagenics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.